New Study to Get More Minorities Involved in Genetic Testing
836 articles
Focusing on a Drug that Treats Specific Tumor Mutations
A clinical trial tests a signal-inhibiting drug for lung cancers with specific genetic mutations on gastrointestinal cancers with the same tumor mutations.
Targeted Therapy for Pancreatic Cancer
Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.
Vitamin C Plus Standard Chemo Improves Overall Survival
Dr. Joseph Cullen believes intravenous vitamin C can help pancreatic cancer patients and his most recent trial results back this up.
What To Do When Newly Diagnosed with Pancreatic Cancer
An oncologist, surgeon, and nurse advocate give their recommendations if you are newly diagnosed with pancreatic cancer.
New Study Focuses On Supportive Oncology Care At Home
Dr. Ryan Nipp is exploring the value of supportive oncology care at home for pancreatic cancer patients in a pilot clinical trial.
Platform Trial Design Aims to Get Information Quickly and Efficiently
Dr. Eugene Koay is leading a platform trial, for a more nimble way to adapt to participants’ response to treatments being tested.
Highlights from the 2025 AACR Annual Meeting
Drugs to target KRAS, better imaging for earlier detection, and cachexia prediction are among the research highlights from AACR 2025.
Using the Energy Around Me to Help Me Heal
Judith Glaser’s genetic mutation influenced her chemotherapy and radiation treatments, supported by the healing energy of friends.
A PARP Inhibitor Approval for Pancreatic Cancer
PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.
Most Cancer Mutations Are Random DNA Mistakes
In a large study, Dr. Bert Vogelstein of Johns Hopkins found that a majority of cancers, including pancreatic cancer, are caused by random mutations of DNA.
New Data Support Preoperative Chemoradiation Regimen for Borderline Resectable Pancreatic Cancer
Should patients get chemotherapy or chemoradiation before surgery? Dr. Matthew Katz provides an update on the Alliance study.
Fighting On To See Her Children Grow Up
Despite aggressive pancreatic cancer, with a BRCA-like genetic mutation, Dr. Jill Pechacek is determined to stay alive to see her children grow up.
Testing an Approved Drug for a Specific Mutation
Researchers are testing a drug combination for melanoma in pancreatic cancer patients with a BRAF genetic mutation.
Chemotherapy Plus Stem Cell Infusion and Vitamins for BRCA Mutated Pancreatic Cancer
A clinical trial for pancreatic cancer patients with a BRCA mutation uses a combination of chemotherapy, vitamins, and stem cells.
Testing a New Immunotherapy Combo in Advanced Pancreatic Cancer
Researchers are testing an approved immunotherapy drug with a new drug that works on T cells to make it more effective for pancreatic cancer.